Not exact matches
Reporting in the Journal of Clinical Investigation Insights, a team led by senior author Andrea Facciabene, PhD, a research assistant professor of Radiation Oncology and Obstetrics / Gynecology, found that the effectiveness of
adoptive T
cell therapy (ACT) in mice with cancer is significantly affected by differences in the natural makeup of gut bacteria and
treatment with antibiotics.
Newer cancer
treatments, like
adoptive T
cell therapy, use a variety of ways to strengthen T
cells for the fight and He says the mouse receptor genes could be another way to do that.
A noted expert in his field, Dr. Collins has since the late 1980s helped to develop the
treatment known as
adoptive immunotherapy, which involves manipulating a donor's immune system so that it attacks cancer
cells.
These
treatments can be broken into four categories: monoclonal antibodies, checkpoint inhibitors and immune modulators, cancer vaccines, and
adoptive cell therapy.
These
treatments can be broken into 5 main categories: checkpoint inhibitors / immune modulators,
adoptive cell transfer, monoclonal antibodies, therapeutic vaccines, and cytokines.
Nicholas P Restifo, MD, National Cancer Institute, Center for Cancer Research, «Developing Curative Cancer
Treatments Using
Adoptive Cell Transfer - Based Immunotherapies»